Abstract
Background: The diagnosis of cancer sets off a cascade of complex decisions at a time when patients feel vulnerable and distressed. Although clinical decisions used to follow one standard, many guidelines now outline several options and include explicit recognition of the need to incorporate patients’ preferences to determine the most appropriate treatment.Purpose: The purpose of this article is to provide a brief overview of empirical studies about cancer patients’treatment-related decision making, to highlight the areas of congruence and divergence in that empirical literature, and then to generate a framework that points to future interventions and research.Methods: Through a group discussion with a range of experts in the field, we generated a framework for the critical treatment decisions and key issues within those decisions. Then, we reviewed the literature describing the experiences of cancer patients and evaluating interventions designed to improve the quality of treatment decisions.Results: We identified four major differences that influence decision making across cancers and across individuals with the same diagnosis.We also identified four common themes across situations and people. There is considerable evidence that decision aids can improve the quality of decisions across a range of diseases, although the data for cancer treatment decision making are limited. Other interventions such as navigation-skill training are promising but have little evidence of benefit for cancer decisions.Conclusions: There are many opportunities for behavioral research to extend and contribute to the understanding and improvement of cancer treatment decision making. Some key areas in need of research include developing taxonomies of disease and patient characteristics and increasing understanding of the lived experiences of cancer survivors, of the influence of time and timing, of the relationship of information and preferences, and of participation in randomized clinical trials.
Similar content being viewed by others
References
Spiegel D: How do you feel about cancer now? Survival and psychosocial support.Public Health Report. 1995,110:298–300.
Nordin K, Berglund G, Glimelius B, Sjoden PO: Predicting anxiety and depression among cancer patients: A clinical model.European Journal of Cancer. 2001,37:376–384.
Scarth H, Cantin J, Levine M, et al.: Clinical practice guidelines for the care and treatment of breast cancer: Mastectomy or lumpectomy? The choice of operation for clinical stages I and II breast cancer (summary of the 2002 update).Canadian Medical Association Journal. 2002,167:154–155.
Arora N: Interacting with cancer patients: The significance of physicians’ communication behavior.Social Science & Medicine. 2003,57:791–806.
Smith RA, Cokkinides V, Eyre HJ: American Cancer Society guidelines for the early detection of cancer.CA: Cancer Journal for Clinicians. 2005,55:31–44.
Krupat E, Fancey M, Cleary PD: Information and its impact on satisfaction among surgical patients.Social Science & Medicine. 2000,51:1817–1825.
Ford S, Fallowfield L, Lewis S: Can oncologists detect distress in the out-patients and how satisfied are they with their performance during bad news consultations?British Journal of Cancer. 1994,70:767–770.
Meade CD: Cancer, culture and literacy: Critical next steps in improving care for diverse populations.Cancer Control. 2005,12:4–5.
Tercyak KP, Lerman C, Peshkin BN, et al.: Effects of coping style and BRCA1 and BRCA2 test results on anxiety among women participating in genetic counseling and testing for breast and ovarian cancer risk.Health Psychology. 2001,20:217–222.
Bowman KF, Deimling GT, Smerglia V, Sage V, Kahana B: Appraisal of the cancer experience by older adult long term survivors.Pyscho-oncology. 2002,12:226–238.
Hall WH, Jani AB, Ryan JK, Narayan S, Vigazakamar S: Impact of age and comorbidity on survival outcomes and treatment patterns in prostate cancer.Prostate Cancer and Prostatic Disease. 2005,8:22–30.
Montgomery GH, Erblich J, DiLorenzo T, Bovbjerg DH: Family and friends with disease: Their impact on perceived risk.Preventive Medicine. 2003,37:242–249.
Weber BA, Sherwill-Navarro P: Psychosocial consequences of prostate cancer: 30 years of research.Geriatric Nursing. 2005,26:166–175.
Spencer S, Lehman J,Wynings C, et al.: Concerns about breast cancer and relations to psychosocial well-being in a multiethnic sample of early-stage patients.Health Psychology. 1999,18:159–168.
Taylor K, Lamdan R, Siegel J, et al.: Treatment regimen, sexual attractiveness concerns and psychological adjustment among African American breast cancer patients.Psycho-oncology. 2002,11:505–517.
Randall TC, Armstrong K: Differences in treatment and outcome between African-American and white women with endometrial cancer.Journal of Clinical Oncology. 2003,15:4200–4206.
Wennberg J, Fisher E, Skinner gnJ: Geography and the debate over Medicare reform.Health Affairs. 2002,Supp Web Exclusives: W94-W114.
Nattinger AB, Gottleib MS, Veum J, Yahnke D, Goodwin JS: Geographic variations in the use of breast conserving treatments.New England Journal of Medicine. 1992,326:1102–1107.
Graefen M,Walz J, Chun KH, et al.: Reasonable delay of surgical treatment in men with localized prostate cancer—Impact on prognosis?European Urology. 2005,47:756–760.
Lee DK, Allareddy V, O’Donnell MA, Williams RD, Konety BR: Does the interval between prostate biopsy and radical prostatectomy affect the immediate post-operative outcome?BJU International. 2006,97:48–50.
Terhaard CH, Kal HB, Hordijk GJ: Why to start the concomitant boost in accelerated radiotherapy for advanced laryngeal cancer in week 3.International Journal Radiation Oncology and Biological Physics. 2005,62:62–69.
Janis I, Mann L:Decision Making. NewYork: Free Press, 1977.
Fisher B, Anderson S, Bryant J, et al.: Twenty-year follow-up of a randomized trial comparing total mastectomy, lumpectomy, and lumpectomy plus irradiation for the treatment of invasive breast cancer.New England Journal of Medicine. 2002,347:1233–1241.
Veronesi U, Cascinelli N, Mariani L, et al.: Twenty-year follow-up of a randomized study comparing breast-conserving surgery with radical mastectomy for early breast cancer.New England Journal of Medicine. 2002,347:1227–1232.
Katz SJ, Lantz PM, Janz NK, et al.: Patient involvement in surgery treatment decisions for breast cancer.Journal of Clinical Oncology. 2005,23:5526–5533.
McNeil BJ, Weischelbaum R, Pauker SG: Speech and survival: Tradeoffs between quality and quantity of life in laryngeal cancer.New England Journal of Medicine. 1981,305:982–987.
Feldman-Stewart D, Brundage MD, Van Manen L, Svenson O: Patient-focused decision-making in early-stage prostate cancer: Insights from a cognitively based decision aid.Health Expectations. 2004,7:126–141.
Phipps E, True G, Harris D, et al.: Approaching the end of life: Attitudes, preferences, and behaviors of African-American and white patients and their family caregivers.Journal of Clinical Oncology. 2003,21:549–554.
Arora N: Interacting with cancer patients: The significance of Physicians’ communication behavior.Social Science & Medicine. 2003,57:791–806.
Jahraus D, Sokolosky S, Thurston N, Guo D: Evaluation of an education program for patients with breast cancer receiving radiation therapy.Cancer Nursing. 2002,25:266–275.
Belkora J:Going to the Doctor?Retrieved February 28, 2006 from http://www.guidesmith.org/going-to-the-doctor/
Thompson SC, Pitts JS, Schwankovsky L: Preferences for involvement in medical decision-making: Situational and demographic influences.Patient Education and Counseling. 1993,22:133–140.
Wallberg B, Michelson H, Nystedt M, et al.: Information needs and preferences for participation in treatment decisions among Swedish breast cancer patients.Acta Oncologica. 2000,39:467–476.
Arora NK, McHorney CA: Patient preferences for medical decision making: Who really wants to participate?Medical Care. 2000,38:335–341.
Kelner M: Activists and delegators: Elderly patients’ preferences about control at the end of life.Social Science & Medicine. 1995,41:537–545.
Bruera E, Willey JS, Palmer JL, Rosales M: Treatment decisions for breast carcinoma: Patient preferences and physician perceptions.Cancer. 2002,94:2076–2080.
Butow P, Maclean M, Dunn S, Tattersall M, Boyer M: The dynamics of change: Cancer patients’ preferences for information, involvement and support.Annals of Oncology. 1997,8:857–863.
Say R, Murtagh M, Thomson R: Patients’ preference for involvement in medical decision making: A narrative review.Patient Education and Counseling. 2006,60:102–114.
Jansen SJ, Otten W, Stiggelbout AM: Review of determinants of patients’ preferences for adjuvant therapy in cancer.Journal of Clinical Oncology. 2004,22:3181–3190.
Gabbay BB, Matsumura S, Etzioni S, et al.: Negotiating end-of-life decision making: A comparison of Japanese and U.S. residents’ approaches.Academic Medicine. 2005,80:617–621.
Roberts JA, Brown D, Elkins T, Larson DB: Factors influencing views of patients with gynecologic cancer about end-of-life decisions.American Journal of Obstetrics & Gynecology. 1997,176:166–172.
Patel HR, Mirsadraee S, Emberton M: The patient’s dilemma: Prostate cancer treatment choices.Journal of Urology. 2003,169:828–833.
Silvestri GA, Knittig S, Zoller JS, Nietert PJ: Importance of faith on medical decisions regarding cancer care.Journal of Clinical Oncology. 2003,21:1379–1382.
Liang W, Burnett CB, Rowland JH, et al.: Communication between physicians and older women with localized breast cancer: Implications for treatment and patient satisfaction.Journal of Clinical Oncology. 2002,20:1008–1016.
Sainio C, Eriksson E, Lauri S: Patient participation in decision making about care.Cancer Nursing. 2001,24:172–179.
Roter D, Stewart M, Putnam S, et al.: Communication patterns of primary care physicians.Journal of the American Medical Association. 1997,277:350–356.
Suchman AL, Markakis K, Beckman HB, Frankel R: A model of empathic communication in the medical interview.Journal of the American Medical Association. 1997,277:678–682.
Sepucha K, Belkora J, Mutchnick S, Esserman L: Consultation planning to help patients prepare for medical consultations: Effect on communication and satisfaction for patients and physicians.Journal of Clinical Oncology. 2002,20:2695–2700.
Bergsma J:Doctors and Patients: Strategies in Long-Term Illness. Boston: Kluwer, 1997.
Gattellari M, Voight KJ, Butow PN, Tattersall MH: When the treatment goal is not cure: Are cancer patients equipped to make informed decisions?Journal of Clinical Oncology. 2002,20:503–513.
Butow PN, Dowsett S, Hagerty R, Tattersall MH: Communicating prognosis to patients with metastatic disease: What do they really want to know?Supportive Care in Center. 2002,10:161–168.
Janz NK, Wren PA, Copeland LA, et al.: Patient-physician concordance: Preferences, perceptions, and factors influencing the breast cancer surgical decision.Journal of Clinical Oncology. 2004,22:3091–3098.
Bruera E, Sweeney C, Calder K, Palmer L, Benisch-Tolley S: Patient preferences versus physician perceptions of treatment decisions in cancer care.Journal of Clinical Oncology. 2001,19:2883–2885.
Institute of Medicine and National Research Council:From Cancer Patient to Cancer Survivor: Lost in Transition. Washington, DC: National Academies Press, 2006.
Kingson ER:Lessons from Joan: Living and Loving with Cancer, a Husband’s Story. Syracuse, NY: Syracuse University Press, 2005.
Bhatnagan V, Kaplan RM: Treatment options for prostate cancer: Evaluating the evidence.American Family Physician. 2005,71:1915–1922.
National Research Council:Networking health: Prescription for the Internet. Washington, DC: National Academic Press, 2000.
Rice RE, Katz JE:The Internet and Health Communication. Thousand Oaks, CA: Sage, 2001.
Blank TO, Adams-Blodnieks M: The who and the what of usage of two cancer online communities.Computers in Human Behavior(in press, 2006).
Sullivan CF: Gendered cybersupport: A thematic analysis of two online cancer support groups.Journal of Health Psychology. 2003,8:83–103.
Stacey D, O’Connor A:A-Z Inventory of Decision Aids. Retrieved August 19, 2005 from http://decisionaid.ohri.ca/ AZinvent.php
Whelan TM, O’Brien MA, Villasis-Keever M, et al.:Impact of Cancer-Related Decision Aids, Evidence Report/Technology Assessment Number 46, (Prepared by McMaster University under Contract No. 290-97-0017.) AHRQ Publication No. 02-E004. Rockville, MD: Agency for Healthcare Research and Quality, July 2002.
O’Connor A, Stacey D, Rovner D, et al.: Decision aids for people facing health treatment or screening decisions.Cochrane Database System Review. 2001,3:CD001431.
O’Connor A, Fiset V, DeGrasse C, et al.: Decision aids for patients considering options affecting cancer outcomes: Evidence of efficacy and policy implications.Journal of the National Cancer Institute Monographs. 1999,25:67–80.
O’Connor A, Elwyn G, Stacey D:IPDAS Voting Document. Retrieved February 28, 2006 from http://ipdas.ohri.ca/IPDAS_ Second_Round.pdf
Psooy BJ, Schreuer D, Borgaonkar J, Caines JS: Patient navigation: Improving timeliness in the diagnosis of breast abnormalities.Canadian Association of Radiologists Journal. 2004,55:145–150.
Brown RF, Butow PN, Dunn SM, Tattersall MH: Promoting patient participation and shortening cancer consultations: A randomised trial.British Journal of Cancer. 2001,85:1273–1279.
Brown R, Butow PN, Boyer MJ, Tattersall MH: Promoting patient participation in the cancer consultation: Evaluation of a prompt sheet and coaching in question-asking.British Journal of Cancer. 1999,80:242–248.
Sepucha K, Belkora J, Tripathy D, Esserman L: Building bridges between physicians and patients: Results of a pilot study examining new tools for collaborative decision making.Journal of Clinical Oncology. 2000,18:1230–1238.
Freeman HP, Chu KC: Determinants of cancer disparities: Barriers to cancer screening, diagnosis, and treatment.Surgical Oncology Clinics of North America. 2005,14:655–669.
Anderson JO, Martin PG: Narratives and healing: Exploring one family’s stories of cancer survivorship.Health Communication. 2003,15:133–143.
Lee CS: Use of narrative in understanding how cancer affects development: The stories of one survivor.Journal of Health Psychology. 2004,6:283–293.
Llewellyn-Thomas HA, Sutherland HJ, Thiel EC: Do patients’ evaluations of a future health state change when they actually enter that state?Medical Care. 1993,31:1002–1012.
Llewellyn-Thomas HA, Schwartz C: Response shift effects in Patients’ evaluations of health states: Sources of artifact. In Schwartz C, Sprangers M (eds),Adaptation to Changing Health: Response Shift in Quality-of-Life Research. Washington, DC: American Psychological Association Press, 2000, 109–122.
O’Connor A, Edwards A: The role of decision aids in promoting evidence-based patient choice. In Edwards A, Elwyn G (eds),Evidence-Based Patient Choice: Inevitable or Impossible? Oxford, UK: Oxford University Press, 2000, 220–242.
Eysenback G, Jadad A: Consumer health informatics in the Internet age. In Edwards A, Elwyn G (eds),Evidence-Based Patient Choice: Inevitable or Impossible? Oxford, UK: Oxford University Press, 2000, 289–307.
Llewellyn-Thomas HA, Sutherland HJ, Tritchler DL, et al.: Benign and malignant breast disease: The relationship between women’s health status and health values.Medical Decision Making. 1991,11:180–188.
Palda VA, Llewellyn-Thomas HA, MacKenzie RG, et al.: Breast cancer patients’ attitudes about rationing postlumpectomy radiation therapy: Applicability of the probability trade-off method to policy-making.Journal of Clinical Oncology. 1997,15:3192–3200.
Holmes-Rovner H, Llewellyn-Thomas H, Edwards G: Moving to the mainstream. In Edwards A, Elwyn G (eds),Evidence- Based Patient Choice: Inevitable or Impossible? Oxford, UK: Oxford University Press, 2000, 270–288.
Llewellyn-Thomas HA, McGreal MJ, Thiel EC, Fine S, Erlichman C: Patients’ willingness to enter clinical trials: Measuring the association with perceived benefit and preference for decision participation.Social Science and Medicine. 1991,32:35–42.
Llewellyn-Thomas HA, McGreal MJ, Thiel EC: Cancer patients’ decision making and trial entry preferences: The effects of "framing" information about short-term toxicity and longterm survival.Medical Decision Making. 1995,15:4–12.
Llewellyn-Thomas HA, Thiel EC, Sem FWC, Harrison-Woermke DE: Presenting clinical trial information: A comparison of methods.Patient Education and Counseling. 1995,25:97–107.
Naylor CD, Llewellyn-Thomas HA: Can there be a more patient- centered approach to determining clinically important effect sizes for randomized treatment trials?Journal of Clinical Epidemiology. 1994,47:787–795.
McPherson K, Britton AR,Wennberg JE: Are randomized controlled trials controlled? Patient preferences and unblind trials.Journal of the Royal Society of Medicine. 1997,90:652–656.
Birkmeyer NJ,Weinstein JN, Tosteson AN, et al.: Design of the Spine Patient Outcomes Research Trial (SPORT).Spine. 2002,27:1361–1372.
Author information
Authors and Affiliations
Corresponding author
Additional information
We thank all who participated in the roundtable discussion of “Treatment Decision Making” at the Preconference workshop “Decision Making in the Cancer Context: Translation from Basic Science through Population Health” at the Society of Behavioral Medicine meetings, April 13, 2005. Authorship contribution was equal and author order is, thus, arbitrary.
About this article
Cite this article
Blank, T., Graves, K., Sepucha, K. et al. Understanding treatment decision making: Contexts, commonalities, complexities, and challenges. ann. behav. med. 32, 211–217 (2006). https://doi.org/10.1207/s15324796abm3203_6
Issue Date:
DOI: https://doi.org/10.1207/s15324796abm3203_6